Pharmaceuticals Global Industry Almanac 2014-2023

Publication ID:

MLI04190452

Publication Date:

April 30, 2019

Pages:

538

Publisher:

麻豆原创Line

Countries:

Global [1]

USD 2,995.00

Pharmaceutical Manufacturing [2]

Country Overview (Pharma & Healthcare) [3]

Pharma & Healthcare [4]

Description:

Pharmaceuticals Global Industry Almanac 2014-2023

Summary

Global Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2014-18, and forecast to 2023). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Essential resource for top-line data and analysis covering the global pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.

Key Highlights

- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- 麻豆原创 values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors).
- Any currency conversions used in the production of this report have been calculated at constant 2018 annual average exchange rates.
- The global pharmaceuticals market had total revenues of $1,111.8m in 2018, representing a compound annual growth rate (CAGR) of 4.5% between 2014 and 2018.
- The performance of the market is forecast to accelerate, with an anticipated CAGR of 5.7% for the five-year period 2018-2023, which is expected to drive the market to a value of $1,469.8m by the end of 2023.
- The USA remains the largest healthcare market in the world, but emerging economies such as China are growing at a significant rate.

Scope

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the global pharmaceuticals market
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global pharmaceuticals market
- Leading company profiles reveal details of key pharmaceuticals market players鈥� global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the global pharmaceuticals market with five year forecasts

Reasons to buy

- What was the size of the global pharmaceuticals market by value in 2018?
- What will be the size of the global pharmaceuticals market in 2023?
- What factors are affecting the strength of competition in the global pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitors in the global pharmaceuticals market?

Table Of Contents:

Table of Contents
EXECUTIVE SUMMARY
麻豆原创 value
麻豆原创 value forecast
Geography segmentation
麻豆原创 share
Introduction
What is this report about?
Who is the target reader?
How to use this report
Definitions
Global Pharmaceuticals
麻豆原创 Overview
麻豆原创 Data
麻豆原创 Segmentation
麻豆原创 outlook
Five forces analysis
Pharmaceuticals in Asia-Pacific
麻豆原创 Overview
麻豆原创 Data
麻豆原创 Segmentation
麻豆原创 outlook
Five forces analysis
Pharmaceuticals in Europe
麻豆原创 Overview
麻豆原创 Data
麻豆原创 Segmentation
麻豆原创 outlook
Five forces analysis
Pharmaceuticals in France
麻豆原创 Overview
麻豆原创 Data
麻豆原创 Segmentation
麻豆原创 outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Germany
麻豆原创 Overview
麻豆原创 Data
麻豆原创 Segmentation
麻豆原创 outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Australia
麻豆原创 Overview
麻豆原创 Data
麻豆原创 Segmentation
麻豆原创 outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Brazil
麻豆原创 Overview
麻豆原创 Data
麻豆原创 Segmentation
麻豆原创 outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Canada
麻豆原创 Overview
麻豆原创 Data
麻豆原创 Segmentation
麻豆原创 outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in China
麻豆原创 Overview
麻豆原创 Data
麻豆原创 Segmentation
麻豆原创 outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in India
麻豆原创 Overview
麻豆原创 Data
麻豆原创 Segmentation
麻豆原创 outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Indonesia
麻豆原创 Overview
麻豆原创 Data
麻豆原创 Segmentation
麻豆原创 outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Italy
麻豆原创 Overview
麻豆原创 Data
麻豆原创 Segmentation
麻豆原创 outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Japan
麻豆原创 Overview
麻豆原创 Data
麻豆原创 Segmentation
麻豆原创 outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Mexico
麻豆原创 Overview
麻豆原创 Data
麻豆原创 Segmentation
麻豆原创 outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in The Netherlands
麻豆原创 Overview
麻豆原创 Data
麻豆原创 Segmentation
麻豆原创 outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in North America
麻豆原创 Overview
麻豆原创 Data
麻豆原创 Segmentation
麻豆原创 outlook
Five forces analysis
Pharmaceuticals in Russia
麻豆原创 Overview
麻豆原创 Data
麻豆原创 Segmentation
麻豆原创 outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Scandinavia
麻豆原创 Overview
麻豆原创 Data
麻豆原创 Segmentation
麻豆原创 outlook
Five forces analysis
Pharmaceuticals in Singapore
麻豆原创 Overview
麻豆原创 Data
麻豆原创 Segmentation
麻豆原创 outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in South Africa
麻豆原创 Overview
麻豆原创 Data
麻豆原创 Segmentation
麻豆原创 outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in South Korea
麻豆原创 Overview
麻豆原创 Data
麻豆原创 Segmentation
麻豆原创 outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Spain
麻豆原创 Overview
麻豆原创 Data
麻豆原创 Segmentation
麻豆原创 outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Turkey
麻豆原创 Overview
麻豆原创 Data
麻豆原创 Segmentation
麻豆原创 outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in The United Kingdom
麻豆原创 Overview
麻豆原创 Data
麻豆原创 Segmentation
麻豆原创 outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in The United States
麻豆原创 Overview
麻豆原创 Data
麻豆原创 Segmentation
麻豆原创 outlook
Five forces analysis
Macroeconomic indicators
Company Profiles
Leading Companies
Appendix
Methodology
About 麻豆原创Line

List of Tables
List of Tables
Table 1: Global pharmaceuticals market value: $ billion, 2014-18
Table 2: Global pharmaceuticals market geography segmentation: $ billion, 2018
Table 3: Global pharmaceuticals market share: % share, by value, 2018
Table 4: Global pharmaceuticals market value forecast: $ billion, 2018-23
Table 5: Asia-Pacific pharmaceuticals market value: $ billion, 2014-18
Table 6: Asia-Pacific pharmaceuticals market geography segmentation: $ billion, 2018
Table 7: Asia-Pacific pharmaceuticals market share: % share, by value, 2018
Table 8: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2018-23
Table 9: Europe pharmaceuticals market value: $ billion, 2014-18
Table 10: Europe pharmaceuticals market geography segmentation: $ billion, 2018
Table 11: Europe pharmaceuticals market share: % share, by value, 2018
Table 12: Europe pharmaceuticals market value forecast: $ billion, 2018-23
Table 13: France pharmaceuticals market value: $ billion, 2014-18
Table 14: France pharmaceuticals market geography segmentation: $ billion, 2018
Table 15: France pharmaceuticals market share: % share, by value, 2018
Table 16: France pharmaceuticals market value forecast: $ billion, 2018-23
Table 17: France size of population (million), 2014-18
Table 18: France gdp (constant 2005 prices, $ billion), 2014-18
Table 19: France gdp (current prices, $ billion), 2014-18
Table 20: France inflation, 2014-18
Table 21: France consumer price index (absolute), 2014-18
Table 22: France exchange rate, 2014-18
Table 23: Germany pharmaceuticals market value: $ billion, 2014-18
Table 24: Germany pharmaceuticals market geography segmentation: $ billion, 2018
Table 25: Germany pharmaceuticals market share: % share, by value, 2018
Table 26: Germany pharmaceuticals market value forecast: $ billion, 2018-23
Table 27: Germany size of population (million), 2014-18
Table 28: Germany gdp (constant 2005 prices, $ billion), 2014-18
Table 29: Germany gdp (current prices, $ billion), 2014-18
Table 30: Germany inflation, 2014-18
Table 31: Germany consumer price index (absolute), 2014-18
Table 32: Germany exchange rate, 2014-18
Table 33: Australia pharmaceuticals market value: $ billion, 2014-18
Table 34: Australia pharmaceuticals market geography segmentation: $ billion, 2018
Table 35: Australia pharmaceuticals market share: % share, by value, 2018
Table 36: Australia pharmaceuticals market value forecast: $ billion, 2018-23
Table 37: Australia size of population (million), 2014-18
Table 38: Australia gdp (constant 2005 prices, $ billion), 2014-18
Table 39: Australia gdp (current prices, $ billion), 2014-18
Table 40: Australia inflation, 2014-18
Table 41: Australia consumer price index (absolute), 2014-18
Table 42: Australia exchange rate, 2014-18
Table 43: Brazil pharmaceuticals market value: $ billion, 2014-18
Table 44: Brazil pharmaceuticals market geography segmentation: $ billion, 2018
Table 45: Brazil pharmaceuticals market share: % share, by value, 2018
Table 46: Brazil pharmaceuticals market value forecast: $ billion, 2018-23
Table 47: Brazil size of population (million), 2014-18
Table 48: Brazil gdp (constant 2005 prices, $ billion), 2014-18
Table 49: Brazil gdp (current prices, $ billion), 2014-18
Table 50: Brazil inflation, 2014-18
Table 51: Brazil consumer price index (absolute), 2014-18
Table 52: Brazil exchange rate, 2014-18
Table 53: Canada pharmaceuticals market value: $ billion, 2014-18
Table 54: Canada pharmaceuticals market geography segmentation: $ billion, 2018
Table 55: Canada pharmaceuticals market share: % share, by value, 2018
Table 56: Canada pharmaceuticals market value forecast: $ billion, 2018-23
Table 57: Canada size of population (million), 2014-18
Table 58: Canada gdp (constant 2005 prices, $ billion), 2014-18
Table 59: Canada gdp (current prices, $ billion), 2014-18
Table 60: Canada inflation, 2014-18

List of Figures
List of Figures
Figure 1: Global pharmaceuticals market value: $ billion, 2014-18
Figure 2: Global pharmaceuticals market geography segmentation: % share, by value, 2018
Figure 3: Global pharmaceuticals market share: % share, by value, 2018
Figure 4: Global pharmaceuticals market value forecast: $ billion, 2018-23
Figure 5: Forces driving competition in the global pharmaceuticals market, 2018
Figure 6: Drivers of buyer power in the global pharmaceuticals market, 2018
Figure 7: Drivers of supplier power in the global pharmaceuticals market, 2018
Figure 8: Factors influencing the likelihood of new entrants in the global pharmaceuticals market, 2018
Figure 9: Factors influencing the threat of substitutes in the global pharmaceuticals market, 2018
Figure 10: Drivers of degree of rivalry in the global pharmaceuticals market, 2018
Figure 11: Asia-Pacific pharmaceuticals market value: $ billion, 2014-18
Figure 12: Asia-Pacific pharmaceuticals market geography segmentation: % share, by value, 2018
Figure 13: Asia-Pacific pharmaceuticals market share: % share, by value, 2018
Figure 14: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2018-23
Figure 15: Forces driving competition in the pharmaceuticals market in Asia-Pacific, 2018
Figure 16: Drivers of buyer power in the pharmaceuticals market in Asia-Pacific, 2018
Figure 17: Drivers of supplier power in the pharmaceuticals market in Asia-Pacific, 2018
Figure 18: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Asia-Pacific, 2018
Figure 19: Factors influencing the threat of substitutes in the pharmaceuticals market in Asia-Pacific, 2018
Figure 20: Drivers of degree of rivalry in the pharmaceuticals market in Asia-Pacific, 2018
Figure 21: Europe pharmaceuticals market value: $ billion, 2014-18
Figure 22: Europe pharmaceuticals market geography segmentation: % share, by value, 2018
Figure 23: Europe pharmaceuticals market share: % share, by value, 2018
Figure 24: Europe pharmaceuticals market value forecast: $ billion, 2018-23
Figure 25: Forces driving competition in the pharmaceuticals market in Europe, 2018
Figure 26: Drivers of buyer power in the pharmaceuticals market in Europe, 2018
Figure 27: Drivers of supplier power in the pharmaceuticals market in Europe, 2018
Figure 28: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Europe, 2018
Figure 29: Factors influencing the threat of substitutes in the pharmaceuticals market in Europe, 2018
Figure 30: Drivers of degree of rivalry in the pharmaceuticals market in Europe, 2018
Figure 31: France pharmaceuticals market value: $ billion, 2014-18
Figure 32: France pharmaceuticals market geography segmentation: % share, by value, 2018
Figure 33: France pharmaceuticals market share: % share, by value, 2018
Figure 34: France pharmaceuticals market value forecast: $ billion, 2018-23
Figure 35: Forces driving competition in the pharmaceuticals market in France, 2018
Figure 36: Drivers of buyer power in the pharmaceuticals market in France, 2018
Figure 37: Drivers of supplier power in the pharmaceuticals market in France, 2018
Figure 38: Factors influencing the likelihood of new entrants in the pharmaceuticals market in France, 2018
Figure 39: Factors influencing the threat of substitutes in the pharmaceuticals market in France, 2018
Figure 40: Drivers of degree of rivalry in the pharmaceuticals market in France, 2018
Figure 41: Germany pharmaceuticals market value: $ billion, 2014-18
Figure 42: Germany pharmaceuticals market geography segmentation: % share, by value, 2018
Figure 43: Germany pharmaceuticals market share: % share, by value, 2018
Figure 44: Germany pharmaceuticals market value forecast: $ billion, 2018-23
Figure 45: Forces driving competition in the pharmaceuticals market in Germany, 2018
Figure 46: Drivers of buyer power in the pharmaceuticals market in Germany, 2018
Figure 47: Drivers of supplier power in the pharmaceuticals market in Germany, 2018
Figure 48: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Germany, 2018
Figure 49: Factors influencing the threat of substitutes in the pharmaceuticals market in Germany, 2018
Figure 50: Drivers of degree of rivalry in the pharmaceuticals market in Germany, 2018
Figure 51: Australia pharmaceuticals market value: $ billion, 2014-18
Figure 52: Australia pharmaceuticals market geography segmentation: % share, by value, 2018
Figure 53: Australia pharmaceuticals market share: % share, by value, 2018
Figure 54: Australia pharmaceuticals market value forecast: $ billion, 2018-23
Figure 55: Forces driving competition in the pharmaceuticals market in Australia, 2018
Figure 56: Drivers of buyer power in the pharmaceuticals market in Australia, 2018
Figure 57: Drivers of supplier power in the pharmaceuticals market in Australia, 2018
Figure 58: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Australia, 2018
Figure 59: Factors influencing the threat of substitutes in the pharmaceuticals market in Australia, 2018
Figure 60: Drivers of degree of rivalry in the pharmaceuticals market in Australia, 2018

Companies Mentioned:

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.